INSM
Income statement / Annual
Last year (2024), Insmed Incorporated's total revenue was $363.71 M,
an increase of 19.17% from the previous year.
In 2024, Insmed Incorporated's net income was -$913.77 M.
See Insmed Incorporated,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$363.71 M |
$305.21 M |
$245.36 M |
$188.46 M |
$164.41 M |
$136.47 M |
$9.84 M |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$85.74 M
|
$65.57 M
|
$55.13 M
|
$44.15 M
|
$39.87 M
|
$24.21 M
|
$2.42 M
|
$2.90 M
|
$2.44 M
|
$1.98 M
|
| Gross Profit |
$277.97 M
|
$239.64 M
|
$190.23 M
|
$144.31 M
|
$124.54 M
|
$112.26 M
|
$7.41 M
|
-$2.90 M
|
-$2.44 M
|
-$1.98 M
|
| Gross Profit Ratio |
0.76
|
0.79
|
0.78
|
0.77
|
0.76
|
0.82
|
0.75
|
0
|
0
|
0
|
| Research and Development Expenses |
$598.37 M
|
$571.01 M
|
$397.52 M
|
$272.74 M
|
$181.16 M
|
$131.71 M
|
$145.28 M
|
$109.75 M
|
$122.72 M
|
$74.28 M
|
| General & Administrative Expenses |
$461.12 M
|
$344.50 M
|
$265.78 M
|
$234.27 M
|
$203.61 M
|
$210.80 M
|
$168.22 M
|
$79.17 M
|
$50.68 M
|
$43.22 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$461.12 M
|
$344.50 M
|
$265.78 M
|
$234.27 M
|
$203.61 M
|
$210.80 M
|
$168.22 M
|
$79.17 M
|
$50.68 M
|
$43.22 M
|
| Other Expenses |
$96.73 M
|
$33.75 M
|
-$15.75 M
|
$12.39 M
|
$5.00 M
|
$4.99 M
|
$1.25 M
|
$300.00 K
|
$119.00 K
|
-$33.00 K
|
| Operating Expenses |
$1.16 B
|
$949.26 M
|
$647.55 M
|
$519.40 M
|
$389.77 M
|
$347.50 M
|
$314.75 M
|
$188.92 M
|
$173.40 M
|
$117.49 M
|
| Cost And Expenses |
$1.24 B
|
$1.01 B
|
$702.68 M
|
$563.56 M
|
$429.65 M
|
$371.71 M
|
$317.17 M
|
$188.92 M
|
$173.40 M
|
$117.49 M
|
| Interest Income |
$53.31 M
|
$42.13 M
|
$11.08 M
|
$174.00 K
|
$1.70 M
|
$9.92 M
|
$10.34 M
|
$1.62 M
|
$604.00 K
|
$261.00 K
|
| Interest Expense |
$84.91 M
|
$81.69 M
|
$26.45 M
|
$40.47 M
|
$29.56 M
|
$27.71 M
|
$25.47 M
|
$5.93 M
|
$3.50 M
|
$2.89 M
|
| Depreciation & Amortization |
$11.01 M
|
$10.58 M
|
$10.33 M
|
$14.18 M
|
$14.15 M
|
$10.18 M
|
$4.83 M
|
$2.90 M
|
$2.44 M
|
$1.98 M
|
| EBITDA |
-$818.79 M |
-$660.18 M |
-$447.37 M |
-$383.65 M |
-$250.37 M |
-$217.07 M |
-$295.18 M |
-$184.10 M |
-$170.24 M |
-$115.28 M |
| EBITDA Ratio |
-2.25
|
-2.16
|
-1.82
|
-2.04
|
-1.52
|
-1.59
|
-30.01
|
0
|
0
|
0
|
| Operating Income Ratio |
-2.41
|
-2.33
|
-1.86
|
-1.99
|
-1.61
|
-1.72
|
-31.25
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$31.81 M
|
-$37.39 M
|
-$22.83 M
|
-$61.32 M
|
-$27.46 M
|
-$18.32 M
|
-$16.74 M
|
-$4.00 M
|
-$2.78 M
|
-$2.66 M
|
| Income Before Tax |
-$910.07 M
|
-$747.01 M
|
-$480.15 M
|
-$436.41 M
|
-$292.69 M
|
-$253.56 M
|
-$324.08 M
|
-$192.92 M
|
-$176.18 M
|
-$120.15 M
|
| Income Before Tax Ratio |
-2.5
|
-2.45
|
-1.96
|
-2.32
|
-1.78
|
-1.86
|
-32.95
|
0
|
0
|
0
|
| Income Tax Expense |
$3.71 M
|
$2.56 M
|
$1.38 M
|
-$1.76 M
|
$1.40 M
|
$777.00 K
|
$201.00 K
|
-$272.00 K
|
$98.00 K
|
-$1.97 M
|
| Net Income |
-$913.77 M
|
-$749.57 M
|
-$481.53 M
|
-$434.65 M
|
-$294.09 M
|
-$254.34 M
|
-$324.28 M
|
-$192.65 M
|
-$176.27 M
|
-$118.18 M
|
| Net Income Ratio |
-2.51
|
-2.46
|
-1.96
|
-2.31
|
-1.79
|
-1.86
|
-32.97
|
0
|
0
|
0
|
| EPS |
-5.57 |
-5.34 |
-3.91 |
-3.88 |
-3.01 |
-3.01 |
-4.22 |
-2.89 |
-2.85 |
-2.02 |
| EPS Diluted |
-5.57 |
-5.34 |
-3.91 |
-3.88 |
-3.01 |
-3.01 |
-4.22 |
-2.89 |
-2.85 |
-2.02 |
| Weighted Average Shares Out |
$164.04 M
|
$140.43 M
|
$123.04 M
|
$112.11 M
|
$97.61 M
|
$84.56 M
|
$76.84 M
|
$66.58 M
|
$61.85 M
|
$58.51 M
|
| Weighted Average Shares Out Diluted |
$164.04 M
|
$140.43 M
|
$123.04 M
|
$112.11 M
|
$97.61 M
|
$84.56 M
|
$76.89 M
|
$66.58 M
|
$61.89 M
|
$58.63 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
